Return On Assets in % of RELMADA THERAPEUTICS, INC. from 2013 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
RELMADA THERAPEUTICS, INC. quarterly/annual Return On Assets history and change rate from 2013 to Q3 2025.
  • RELMADA THERAPEUTICS, INC. Return On Assets for the quarter ending 30 Sep 2025 was -205 %, a 83.1% decline year-over-year.
  • RELMADA THERAPEUTICS, INC. annual Return On Assets for 2024 was -124 %, a 46.3% decline from 2023.
  • RELMADA THERAPEUTICS, INC. annual Return On Assets for 2023 was -85.1 %, a 5.9% decline from 2022.
  • RELMADA THERAPEUTICS, INC. annual Return On Assets for 2022 was -80.4 %, a 15.5% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

RELMADA THERAPEUTICS, INC. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -205 -93.2 -83.1% 01 Jul 2025 30 Sep 2025
Q2 2025 -180 -84.6 -88.3% 01 Apr 2025 30 Jun 2025
Q1 2025 -151 -59.9 -65.6% 01 Jan 2025 31 Mar 2025
Q4 2024 -124 -39.4 -46.3% 01 Oct 2024 31 Dec 2024
Q3 2024 -112 -26.2 -30.5% 01 Jul 2024 30 Sep 2024
Q2 2024 -95.8 -9.5 -11% 01 Apr 2024 30 Jun 2024
Q1 2024 -91.3 -8.2 -9.87% 01 Jan 2024 31 Mar 2024
Q4 2023 -85.1 -4.74 -5.9% 01 Oct 2023 31 Dec 2023
Q3 2023 -85.9 -13.8 -19.2% 01 Jul 2023 30 Sep 2023
Q2 2023 -86.3 -3.42 -4.13% 01 Apr 2023 30 Jun 2023
Q1 2023 -83.1 +4.97 +5.64% 01 Jan 2023 31 Mar 2023
Q4 2022 -80.4 +14.7 +15.5% 01 Oct 2022 31 Dec 2022
Q3 2022 -72.1 +33.8 +31.9% 01 Jul 2022 30 Sep 2022
Q2 2022 -82.9 -7.49 -9.93% 01 Apr 2022 30 Jun 2022
Q1 2022 -88.1 -29.2 -49.5% 01 Jan 2022 31 Mar 2022
Q4 2021 -95.1 -46.9 -97.5% 01 Oct 2021 31 Dec 2021
Q3 2021 -106 -70.8 -202% 01 Jul 2021 30 Sep 2021
Q2 2021 -75.4 -43.5 -136% 01 Apr 2021 30 Jun 2021
Q1 2021 -58.9 -22.3 -60.9% 01 Jan 2021 31 Mar 2021
Q4 2020 -48.2 -4.82 -11.1% 01 Oct 2020 31 Dec 2020
Q3 2020 -35.1 +251 +87.7% 01 Jul 2020 30 Sep 2020
Q2 2020 -31.9 +360 +91.8% 01 Apr 2020 30 Jun 2020
Q1 2020 -36.6 +593 +94.2% 01 Jan 2020 31 Mar 2020
Q4 2019 -43.3 +494 +91.9% 01 Oct 2019 31 Dec 2019
Q3 2019 -286 -1.42 -0.5% 01 Jul 2019 30 Sep 2019
Q2 2019 -392 -213 -119% 01 Apr 2019 30 Jun 2019
Q1 2019 -630 -484 -331% 01 Jan 2019 31 Mar 2019
Q4 2018 -537 -412 -328% 01 Oct 2018 31 Dec 2018
Q3 2018 -284 -165 -138% 01 Jul 2018 30 Sep 2018
Q2 2018 -179 -60.1 -50.5% 01 Apr 2018 30 Jun 2018
Q1 2018 -146 -34.6 -31% 01 Jan 2018 31 Mar 2018
Q4 2017 -126 -40.9 -48.4% 01 Oct 2017 31 Dec 2017
Q3 2017 -119 -41.3 -52.8% 01 Jul 2017 30 Sep 2017
Q2 2017 -119 -99.1 -500% 01 Apr 2017 30 Jun 2017
Q1 2017 -112 -146 -424% 01 Jan 2017 31 Mar 2017
Q4 2016 -84.6 -110 -427% 01 Oct 2016 31 Dec 2016
Q3 2016 -78.2 -130 -251% 01 Jul 2016 30 Sep 2016
Q2 2016 -19.8 +53.9 +73.1% 01 Apr 2016 30 Jun 2016
Q1 2016 34.4 01 Jan 2016 31 Mar 2016
Q4 2015 25.9 01 Oct 2015 31 Dec 2015
Q3 2015 51.9 01 Jul 2015 30 Sep 2015
Q2 2015 -73.7 01 Apr 2015 30 Jun 2015

RELMADA THERAPEUTICS, INC. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -124 -39.4 -46.3% 01 Jan 2024 31 Dec 2024
2023 -85.1 -4.74 -5.9% 01 Jan 2023 31 Dec 2023
2022 -80.4 +14.7 +15.5% 01 Jan 2022 31 Dec 2022
2021 -95.1 -46.9 -97.5% 01 Jan 2021 31 Dec 2021
2020 -48.2 -4.82 -11.1% 01 Jan 2020 31 Dec 2020
2019 -43.3 +136 +75.8% 01 Jan 2019 31 Dec 2019
2018 -179 -60.1 -50.5% 01 Jul 2017 30 Jun 2018
2017 -119 -99.1 -500% 01 Jul 2016 30 Jun 2017
2016 -19.8 +53.9 +73.1% 01 Jul 2015 30 Jun 2016
2015 -73.7 01 Jul 2014 30 Jun 2015
2013 -336 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.